[go: up one dir, main page]

DE60027890D1 - Streptococcus pneumoniae proteine und impfstoffe - Google Patents

Streptococcus pneumoniae proteine und impfstoffe

Info

Publication number
DE60027890D1
DE60027890D1 DE60027890T DE60027890T DE60027890D1 DE 60027890 D1 DE60027890 D1 DE 60027890D1 DE 60027890 T DE60027890 T DE 60027890T DE 60027890 T DE60027890 T DE 60027890T DE 60027890 D1 DE60027890 D1 DE 60027890D1
Authority
DE
Germany
Prior art keywords
vaccines
streptococcus pneumoniae
pneumoniae proteins
polypeptides
relates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60027890T
Other languages
English (en)
Other versions
DE60027890T2 (de
Inventor
E Adamou
H Choi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Human Genome Sciences Inc
MedImmune LLC
Original Assignee
Human Genome Sciences Inc
MedImmune LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Human Genome Sciences Inc, MedImmune LLC filed Critical Human Genome Sciences Inc
Publication of DE60027890D1 publication Critical patent/DE60027890D1/de
Application granted granted Critical
Publication of DE60027890T2 publication Critical patent/DE60027890T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
    • C07K16/1275—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Streptococcus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C07K14/3156—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci from Streptococcus pneumoniae (Pneumococcus)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE60027890T 1999-06-10 2000-06-09 Streptococcus pneumoniae proteine und impfstoffe Expired - Lifetime DE60027890T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13845399P 1999-06-10 1999-06-10
US138453P 1999-06-10
PCT/US2000/015925 WO2000076540A2 (en) 1999-06-10 2000-06-09 Streptococcus pneumoniae proteins and vaccines

Publications (2)

Publication Number Publication Date
DE60027890D1 true DE60027890D1 (de) 2006-06-14
DE60027890T2 DE60027890T2 (de) 2007-04-19

Family

ID=22482080

Family Applications (2)

Application Number Title Priority Date Filing Date
DE60027890T Expired - Lifetime DE60027890T2 (de) 1999-06-10 2000-06-09 Streptococcus pneumoniae proteine und impfstoffe
DE60045721T Expired - Lifetime DE60045721D1 (de) 1999-06-10 2000-06-09 Streptococcus pneumoniae Proteine und Impfstoffe

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE60045721T Expired - Lifetime DE60045721D1 (de) 1999-06-10 2000-06-09 Streptococcus pneumoniae Proteine und Impfstoffe

Country Status (9)

Country Link
EP (2) EP1731166B1 (de)
JP (1) JP2003501110A (de)
AT (2) ATE500843T1 (de)
AU (1) AU777856B2 (de)
CA (1) CA2371714C (de)
DE (2) DE60027890T2 (de)
ES (2) ES2264419T3 (de)
HK (1) HK1043943A1 (de)
WO (1) WO2000076540A2 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7129340B1 (en) 1997-07-02 2006-10-31 sanofi pasteur limited/sanofi pasteur limitée Nucleic acid and amino acid sequences relating to streptococcus pneumoniae for diagnostics and therapeutics
US6800744B1 (en) 1997-07-02 2004-10-05 Genome Therapeutics Corporation Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics
US7128918B1 (en) 1998-12-23 2006-10-31 Id Biomedical Corporation Streptococcus antigens
US7074415B2 (en) 2000-06-20 2006-07-11 Id Biomedical Corporation Streptococcus antigens
GB0022742D0 (en) 2000-09-15 2000-11-01 Smithkline Beecham Biolog Vaccine
EP1456231A2 (de) 2001-12-20 2004-09-15 Shire Biochem Inc. Streptococcus antigene
TWI457133B (zh) 2005-12-13 2014-10-21 Glaxosmithkline Biolog Sa 新穎組合物
GB0607088D0 (en) 2006-04-07 2006-05-17 Glaxosmithkline Biolog Sa Vaccine
CA2634887C (en) 2005-12-22 2016-01-19 Glaxosmithkline Biologicals Sa Capsular saccharide conjugate vaccines against streptococcus pneumoniae
EP2687228B1 (de) 2007-06-26 2017-07-19 GlaxoSmithKline Biologicals S.A. Impfstoff mit streptococcus pneumoniae-kapsulären polysaccharid-konjugaten
GB0714963D0 (en) 2007-08-01 2007-09-12 Novartis Ag Compositions comprising antigens
JP2011506433A (ja) * 2007-12-13 2011-03-03 インターバック アーベー 改変された免疫組成物
HUE027249T2 (en) 2008-03-03 2016-10-28 Novartis Ag TLR activity modulator compounds and preparations
EP2612680B1 (de) 2008-04-16 2018-05-23 GlaxoSmithKline Biologicals SA Impfstoff
EP2440245B1 (de) 2009-06-10 2017-12-06 GlaxoSmithKline Biologicals SA Benzonaphtyridin-enthaltende impfstoffe
SG177402A1 (en) 2009-06-29 2012-02-28 Genocea Biosciences Inc Vaccines and compositions against streptococcus pneumoniae
JO3257B1 (ar) 2009-09-02 2018-09-16 Novartis Ag مركبات وتركيبات كمعدلات لفاعلية tlr
BR112012004806B8 (pt) 2009-09-02 2022-10-04 Novartis Ag composições imunogênicas que incluem moduladores da atividade de tlr, método para aumento da eficácia da referida composição e uso
JP2013504556A (ja) 2009-09-10 2013-02-07 ノバルティス アーゲー 気道疾患に対する組み合わせワクチン
WO2011057148A1 (en) 2009-11-05 2011-05-12 Irm Llc Compounds and compositions as tlr-7 activity modulators
JP5814933B2 (ja) 2009-12-15 2015-11-17 ノバルティス アーゲー 免疫増強化合物の均質な懸濁物およびその使用
GB201003924D0 (en) 2010-03-09 2010-04-21 Glaxosmithkline Biolog Sa Immunogenic composition
EA031379B1 (ru) 2010-03-23 2018-12-28 Новартис Аг Соединения (липопептиды на основе цистеина) и композиции в качестве агонистов tlr2, применяемые для лечения инфекционных, воспалительных, респираторных и других заболеваний
WO2012072769A1 (en) 2010-12-01 2012-06-07 Novartis Ag Pneumococcal rrgb epitopes and clade combinations
KR20140017554A (ko) 2011-01-20 2014-02-11 제노시아 바이오사이언스, 인크. 폐렴 구균에 대한 백신 및 조성물
CN103533953A (zh) 2011-05-17 2014-01-22 葛兰素史密丝克莱恩生物有限公司 针对肺炎链球菌的疫苗
JP2015510872A (ja) 2012-03-07 2015-04-13 ノバルティス アーゲー Ｓｔｒｅｐｔｏｃｏｃｃｕｓｐｎｅｕｍｏｎｉａｅ抗原の増強された製剤
US9827190B2 (en) 2013-02-01 2017-11-28 Glaxosmithkline Biologicals Sa Intradermal delivery of immunological compositions comprising toll-like receptor 7 agonists
EP3752182B1 (de) 2018-02-12 2024-05-15 Inimmune Corporation Toll-like-rezeptorliganden
US11820989B2 (en) 2020-11-04 2023-11-21 Eligo Bioscience Phage-derived particles for in situ delivery of DNA payload into C. acnes population

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998018931A2 (en) * 1996-10-31 1998-05-07 Human Genome Sciences, Inc. Streptococcus pneumoniae polynucleotides and sequences
JP2002521058A (ja) * 1998-07-27 2002-07-16 マイクロビアル テクニクス リミティッド 肺炎連鎖球菌由来の核酸及びタンパク質

Also Published As

Publication number Publication date
EP1185297A2 (de) 2002-03-13
ES2264419T3 (es) 2007-01-01
EP1731166B1 (de) 2011-03-09
EP1731166A2 (de) 2006-12-13
AU5477800A (en) 2001-01-02
EP1185297B1 (de) 2006-05-10
DE60045721D1 (de) 2011-04-21
ES2360296T3 (es) 2011-06-02
WO2000076540A3 (en) 2001-02-08
HK1043943A1 (zh) 2002-10-04
CA2371714C (en) 2012-12-04
JP2003501110A (ja) 2003-01-14
CA2371714A1 (en) 2000-12-21
WO2000076540A2 (en) 2000-12-21
ATE325620T1 (de) 2006-06-15
ATE500843T1 (de) 2011-03-15
DE60027890T2 (de) 2007-04-19
AU777856B2 (en) 2004-11-04
EP1731166A3 (de) 2007-02-21

Similar Documents

Publication Publication Date Title
ATE325620T1 (de) Streptococcus pneumoniae proteine und impfstoffe
NZ512574A (en) Novel streptococcus antigens useful as vaccines
WO2001098334A3 (en) Streptococcus antigens
ATE422899T1 (de) Streptococcus pneumoniae proteine und immunogene fragmente für impstoffe
EP2305822A3 (de) Verfahren und Zusammensetzungen für mit Amyloidose assoziierte Erkrankungen
HUP0002475A2 (hu) Módosított immunogén pneumolizinkészítmények mint vakcinák
ATE276758T1 (de) Adjuvans-zusammensetzung, enthaltend saponin und ein immunstimulatorisches oligonukleotid
DE60036698D1 (de) Chlamydia-antigene und entsprechende dna-fragmente und deren verwendungen
DK0778781T3 (da) Pneumokok-polysaccharid-rekombinant pneumolysin-konjugat-vacciner til immunisering mod pneumokokinfektioner
NO980883D0 (no) Forbindelser og fremgangsmåter for immunterapi og diagnose av tuberkulose
WO2001081380A3 (en) Immunogenic pneumococcal protein and vaccine compositions thereof
WO1999042076A3 (en) Compounds and methods for immunotherapy and diagnosis of tuberculosis
WO2002072036A3 (en) Compositions and methods comprising west nile virus polypeptides
WO1999042588A3 (en) Group b streptococcus antigens
DE60037900D1 (de) Chlamydia antigene und entsprechende dna-fragmente und ihre verwendungen
WO2006065553A3 (en) Glycoconjugate vaccines containing peptidoglycan
NO20015074D0 (no) Nye sammensetninger
WO2002045742A8 (en) Lipoteichoic acid immunogenic compositions and methods of making and using thereof
WO2000058475A3 (en) Streptococcus pneumoniae antigens
EA200100700A1 (ru) Гены и белки и их применение
BR0207447A (pt) Polipeptìdeos e fragmentos de dna correspondentes de streptococcus pyogenes úteis como componentes de vacina
EA200100701A1 (ru) Белки наружной поверхности, их гены и их применение
ATE366583T1 (de) Identifizierung von spezifischen differenziell exprimierten antigenen aus mycobacterium und medizinische verwendung der mycobakteriumproteine rv0068 und rv3407
DE60234772D1 (de) Gruppe-b streptococcus antigene und entsprechende dna-fragmente
ATE401341T1 (de) Vakzine enthaltend omp85 proteine von neisseria gonorrhoeae und neisseria meningitidis

Legal Events

Date Code Title Description
8364 No opposition during term of opposition